Selective peroxisome proliferator-activated receptor-γ (PPARγ) activity of telmisartan prevents vascular injury in type 2 diabetic mice

被引:0
|
作者
Toyama, Kensuke [1 ]
Nakamura, Taishi [1 ]
Fukuda, Masaya [1 ]
Kataoka, Keiichiro [1 ]
Nako, Hisato [1 ]
Dong, YiFei [1 ]
Tokutomi, Yoshiko [1 ]
Ogawa, Hisao [2 ]
Kim-Mitsuyama, Shokei [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto 8608556, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:198P / 198P
页数:1
相关论文
共 50 条
  • [1] Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-γ activation in diabetic mice
    Iwanami, Jun
    Mogi, Masaki
    Tsukuda, Kana
    Min, Li-Juan
    Sakata, Akiko
    Jing, Fei
    Iwai, Masaru
    Horiuchi, Masatsugu
    JOURNAL OF HYPERTENSION, 2010, 28 (08) : 1730 - 1737
  • [2] Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
    Maria Quintela, Ana
    Jimenez, Rosario
    Gomez-Guzman, Manuel
    Jose Zarzuelo, Maria
    Galindo, Pilar
    Sanchez, Manuel
    Vargas, Felix
    Cogolludo, Angel
    Tamargo, Juan
    Perez-Vizcaino, Francisco
    Duarte, Juan
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 53 (04) : 730 - 741
  • [3] Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
    Girroir, Elizabeth E.
    Hollingshead, Holly E.
    He, Pengfei
    Zhu, Bokai
    Perdew, Gary H.
    Peters, Jeffrey M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 371 (03) : 456 - 461
  • [4] Peroxisome proliferator-activated receptor-γ (PPARγ) activity from Cistus saivifolius -: Cistaceae
    Arapogianni, N. E.
    Halabalaki, M.
    Hempel, J.
    Wober, J.
    Skoltsounis, A. L.
    Vollmer, G.
    PLANTA MEDICA, 2007, 73 (09) : 1000 - 1000
  • [5] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Lin Wang
    Yin Cai
    Liguo Jian
    Chi Wai Cheung
    Liangqing Zhang
    Zhengyuan Xia
    Cardiovascular Diabetology, 20
  • [6] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Wang, Lin
    Cai, Yin
    Jian, Liguo
    Cheung, Chi Wai
    Zhang, Liangqing
    Xia, Zhengyuan
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [7] Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention
    Peters J.M.
    Yao P.-L.
    Gonzalez F.J.
    Current Pharmacology Reports, 2015, 1 (2) : 121 - 128
  • [8] Flexible ligand recognition of peroxisome proliferator-activated receptor-γ (PPARγ)
    Yamagishi, Kenji
    Yamamoto, Keiko
    Mochizuki, Yuji
    Nakano, Tatsuya
    Yamada, Sachiko
    Tokiwa, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (11) : 3344 - 3347
  • [9] A Selective Peroxisome Proliferator-Activated Receptor-γ Modulator, Telmisartan, Binds to the Receptor in a Different Fashion from Thiazolidinediones
    Tagami, Tetsuya
    Yamamoto, Hiroyuki
    Moriyama, Kenji
    Sawai, Kuniko
    Usui, Takeshi
    Shimatsu, Akira
    Naruse, Mitsuhide
    ENDOCRINOLOGY, 2009, 150 (02) : 862 - 870
  • [10] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B